Luye Pharma eyes $750m Q2 IPO
China’s Luye Pharma Group is planning to conduct a $750m Hong Kong IPO as early as the second quarter, according to a banker close to the deal.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: